Late in 2018, our federal government announced that in 2019 that it intends to regulate how and when to take Medicare’s future interests into account.
Cross-posted from Optum Insights blog. On April 19, the U.S. Food and Drug Administration (FDA) approved the first generic for Narcan® Nasal Spray, the life-saving medication used for the emergency treatment of opioid-related overdose. After receiving tentative approval last June, Teva Pharmaceuticals USA Inc. has been granted final approval to market naloxone nasal spray. Teva … Read moreFDA approves the first generic naloxone nasal spray to treat opioid overdoses